Miromatrix Medical Inc.
NASDAQ:MIRO
3.39 (USD) • At close December 12, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Revenue
| 0.953 | 0.033 | 0.047 | 0.25 |
| Cost of Revenue
| 0.5 | 0.5 | 0.5 | 0.25 |
| Gross Profit
| 0.453 | -0.467 | -0.453 | 0 |
| Gross Profit Ratio
| 0.476 | -14.121 | -9.746 | 0 |
| Reseach & Development Expenses
| 18.303 | 10.751 | 7.281 | 6.267 |
| General & Administrative Expenses
| 8.72 | 4.643 | 2.109 | 2.436 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 |
| SG&A
| 8.72 | 4.643 | 2.109 | 2.436 |
| Other Expenses
| 3.676 | 0.706 | -0.577 | -0.143 |
| Operating Expenses
| 30.699 | 16.1 | 8.813 | 8.56 |
| Operating Income
| -30.246 | -16.96 | -10.259 | -8.992 |
| Operating Income Ratio
| -31.722 | -512.899 | -220.472 | -35.967 |
| Total Other Income Expenses Net
| 0.286 | 2.289 | -0.051 | -0.535 |
| Income Before Tax
| -29.96 | -14.671 | -10.31 | -9.527 |
| Income Before Tax Ratio
| -31.422 | -443.681 | -221.568 | -38.107 |
| Income Tax Expense
| 0.048 | 0.285 | -1.593 | -6.457 |
| Net Income
| -30.008 | -14.956 | -8.716 | -3.07 |
| Net Income Ratio
| -31.472 | -452.3 | -187.327 | -12.281 |
| EPS
| -1.45 | -1.3 | -0.82 | -0.29 |
| EPS Diluted
| -1.45 | -1.3 | -0.82 | -0.29 |
| EBITDA
| -29.912 | -16.788 | -11.446 | -9.134 |
| EBITDA Ratio
| -31.372 | -507.717 | -245.985 | -36.537 |